Evidence map›Paper›PMID 34884968›Full record

ArticleInternational journal of molecular sciences2021

Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro.

Meng-Hsun Yu, Tung-Wei Hung, Chi-Chih Wang, Sheng-Wen Wu, Tzu-Wei Yang, Ching-Yu Yang, Tsui-Hwa Tseng, Chau-Jong Wang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Multi-Target Anti-Psoriatic Effects ofMolecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Advances in the Regulation of Lipid Metabolism by Non-Coding RNAs.Animals : an open access journal from MDPI · 2025
    Review
  9. Article
  10. Transcriptomic and Proteomic Insights Into Buffalo Milk Fat Synthesis and the Role of IGFBP4 in BMECs.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Frontiers in oncology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Meng-Hsun YuInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Tung-Wei HungDepartment of Medicine, Division of Nephrology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
Chi-Chih WangSchool of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0002-8222-0503
Sheng-Wen WuDepartment of Medicine, Division of Nephrology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
Tzu-Wei YangSchool of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Ching-Yu YangInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Tsui-Hwa TsengDepartment of Medical Applied Chemistry, Chung Shan Medical University, Taichung 40201, Taiwan.
Chau-Jong WangDepartment of Health Industry Technology Management, Chung Shan Medical University, Taichung 40201, Taiwan.
Chung Shan Medical University Hospital · TWChung Shan Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neochlorogenic acid (5-Caffeoylquinic acid; 5-CQA), a major phenolic compound isolated from mulberry leaves, possesses anti-oxidative and anti-inflammatory effects. Although it modulates lipid metabolism, the molecular mechanism is unknown. Using an in-vitro model of nonalcoholic fatty liver disease (NAFLD) in which oleic acid (OA) induced lipid accumulation in HepG2 cells, we evaluated the alleviation effect of 5-CQA. We observed that 5-CQA improved OA-induced intracellular lipid accumulation by downregulating sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FASN) expression, which regulates the fatty acid synthesis, as well as SREBP2 and HMG-CoA reductases (HMG-CoR) expressions, which regulate cholesterol synthesis. Treatment with 5-CQA also increased the expression of fatty acid β-oxidation enzymes. Remarkably, 5-CQA attenuated OA-induced miR-34a expression. A transfection assay with an miR-34a mimic or miR-34a inhibitor revealed that miR-34a suppressed Moreover, Sirtuin 1 (SIRT1) expression and inactivated 5' adenosine monophosphate-activated protein kinase (AMPK). Our results suggest that 5-CQA alleviates lipid accumulation by downregulating miR-34a, leading to activation of the SIRT1/AMPK pathway.

Indexed as

AMP-Activated Protein KinasesCell ProliferationCells, CulturedChlorogenic AcidDiet, High-FatHumansInflammationLipid MetabolismLipogenesisLiverMicroRNAsQuinic AcidSirtuin 15-caffeoylquinic acidAMP-Activated Protein KinasesChlorogenic AcidMicroRNAsMIRN34 microRNA, humanQuinic AcidSIRT1 protein, humanSirtuin 15-CQAcholesterol synthesisfatty acid synthesismiR-34aNAFLD

Identifiers

PMID34884968
PMCPMC8658127
OpenAlexW4200387459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.